Glycosylated polypeptide and drug composition containing said polypeptide

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9937264
SERIAL NO

15205960

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

[Problem] To provide a glycosylated polypeptide having an affinity to somatostatin receptors, and, compared to somatostatins, having improved in-blood stability. [Solution] The glycosylated polypeptide is characterized by at least one amino acid in a somatostatin or an analog thereof being replaced with a glycosylated amino acid.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLYTECH INC134 CHUDOJI-MINAMIMACHI SHIMOGYO-KU KYOTO-SHI KYOTO 600-8813

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fukae, Kazuhiro Kyoto, JP 27 107
Ishii, Kazuyuki Kyoto, JP 17 70
Maeda, Masatoshi Kyoto, JP 31 534
Ochiai, Hirofumi Kyoto, JP 8 20
Shimoda, Taiji Kyoto, JP 9 17
Tazuru, Keisuke Kyoto, JP 6 17
Tezuka, Katsunari Kyoto, JP 38 721
Yoshida, Kenta Kyoto, JP 26 100

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 10, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 10, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00